Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible α-Cell Hyperplasia and Hyperglucagonemia
Year: 2009
Type: article
Authors: Wei Gu, Hai Yan, Katherine A. Winters, Renée Komorowski, Steven Vonderfecht, Larissa Atangan, Glenn Sivits, David Hill, Jie Yang, Vivian Bi, Yuqing Shen, Sylvia Hu, Tom Boone, Richard A. Lindberg, Murielle M. Véniant
Institution: Amgen (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Eli Lilly and Company, LifeScan
OpenAlex ID: W2156888164
